Rituximab + belimumab

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Rituximab + belimumab
Treatment and conditionWhere it standsTrials
Rituximab + belimumab for scleroderma, systemicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1